Provided by Tiger Trade Technology Pte. Ltd.

Cardiff Oncology, Inc.

0.8801
-0.0286-3.15%
Post-market: 0.90700.0269+3.05%19:44 EDT
Volume:653.49K
Turnover:592.10K
Market Cap:68.36M
PE:-1.49
High:0.9289
Open:0.9266
Low:0.8800
Close:0.9087
52wk High:3.31
52wk Low:0.7566
Shares:77.67M
Float Shares:75.24M
Volume Ratio:1.17
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5914
EPS(LYR):-0.6863
ROE:-94.08%
ROA:-46.73%
PB:2.58
PE(LYR):-1.28

Loading ...

Cardiff Oncology to present updated onvansertib Phase 2 mCRC data at ASCO 2026

Reuters
·
Apr 21

Cardiff Oncology to present preclinical data on onvansertib

TIPRANKS
·
Apr 18

Cardiff Oncology reports preclinical onvansertib-T-DXd synergy in HER2-low breast cancer models

Reuters
·
Apr 18

Cardiff Oncology CFO Joshua Muntner files initial beneficial ownership statement

Reuters
·
Apr 17

BRIEF-Cardiff Oncology Announces Key Leadership Appointments To Strengthen Executive Team For Next Phase Of Growth

Reuters
·
Apr 10

Cardiff Oncology names Mani Mohindru CEO, appoints Josh Muntner CFO

Reuters
·
Apr 10

Cardiff Oncology Inc - Appoints Josh Muntner as CFO Effective April 6 and Ajay Aggarwal as COO Effective April 27

THOMSON REUTERS
·
Apr 10

Cardiff Oncology Inc - Appoints Mani Mohindru as President and CEO; to Continue as Board Member

THOMSON REUTERS
·
Apr 10

Cardiff Oncology CEO Mark Erlander resigns as director after stepping down as CEO

Reuters
·
Apr 03

These 16 stocks are a short seller's dream - likely losers no matter what the market does

Dow Jones
·
Mar 29

These 16 stocks are a short seller's dream - likely losers no matter what the market does

Dow Jones
·
Mar 27

Noble Financial Sticks to Its Buy Rating for Cardiff Oncology (CRDF)

TIPRANKS
·
Mar 27

Analysts Are Bullish on These Healthcare Stocks: Cardiff Oncology (CRDF), CSPC Pharmaceutical Group (CHJTF)

TIPRANKS
·
Mar 26

Cardiff Oncology to host KOL webinar on first-line RAS-mutated metastatic colorectal cancer

Reuters
·
Mar 20

Cardiff Oncology to present onvansertib and T-DXd preclinical data at AACR Annual Meeting 2026

Reuters
·
Mar 19

Cardiff Oncology to Participate in Three Upcoming Investor Conferences

Reuters
·
Feb 27

Cardiff Oncology Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 26

Cardiff Oncology Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Feb 25

Analysts Offer Insights on Healthcare Companies: Cardiff Oncology (CRDF) and Alphatec Holdings (ATEC)

TIPRANKS
·
Feb 25

Press Release: Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update

Dow Jones
·
Feb 25